Skip to main content

S. 2326

Referred to Committee

NOVEL Act of 2019

Introduced 7/30/2019•116th Congress•Senate

Latest Action

Read twice and referred to the Committee on Finance.

7/30/2019 • Senate

Summary

New Opportunities for Value that Extend Lives Act of 2019 or the NOVEL Act of 2019

This bill establishes a process for expediting the assignment of Healthcare Common Procedure Coding System (HCPCS) codes to medical products that have been designated as a breakthrough product or regenerative advanced therapy by the Food and Drug Administration; it also establishes a process for determining coverage under Medicare of such breakthrough products that have been assigned HCPCS codes.

Introduced in Senate • 7/30/2019

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Drug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesHealth care costs and insuranceHealth care coverage and accessHealth technology, devices, suppliesManufacturingMedicarePublic participation and lobbying

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (4)

Party Breakdown

2
Democrats
2
Republicans
0
Independents

Sponsor

S[
Sen. Burr, Richard [R-NC]

Republican • NC

Sponsored 7/30/2019

Cosponsors (3)

S[
Sen. Bennet, Michael F. [D-CO]

D-CO

Joined 7/30/2019

S[
Sen. Scott, Tim [R-SC]

R-SC

Joined 7/30/2019

S[
Sen. Carper, Thomas R. [D-DE]

D-DE

Joined 7/30/2019

Bill Journey

Originated in the Senate

Introduced

July 30, 2019

Read twice and referred to the Committee on Finance.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate7/30/2019

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors3